<DOC>
	<DOCNO>NCT01877044</DOCNO>
	<brief_summary>The high prevalence overweight obesity among population contributes increase incidence chronic metabolic disease . Obesity consider low-grade systemic inflammatory condition 1 ) production pro-inflammatory cytokine adipose tissue 2 ) alteration intestinal microbiota composition associate increase intestinal permeability . Healthcare cost related disease rise ; prevention delay onset disorder associate overweight need . Administration wheat arabinoxylans ( NAXUS ) , non-digestible carbohydrate , may change intestinal microbiota composition beneficial effect gut epithelial barrier , especially permeability innate immune function . Objective : To assess effect NAXUS intestinal barrier function , immune system performance metabolic control . Prebiotic property NAXUS study . Tolerance product different dos also investigate .</brief_summary>
	<brief_title>Long-term Effects Arabinoxylans Intestinal Barrier Function</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<criteria>Overweight men/women ( BMI 2835 kg/m2 ) Besides overweight , healthy human being Fasting glucose &lt; 7.0 mmol/L Normal HbA1c ( 4.4 6.2 % ) Consistently stable body weight least 6 month ( ± 2 kg ) Type 2 diabetes mellitus ( define fast plasma glucose ≥ 7.0 mmol/L ) ; Gastroenterological diseases abdominal surgery ; Cardiovascular disease , cancer , liver kidney malfunction , disease life expectancy short 5 year ; Abuse product ; alcohol ( &gt; 20 alcoholic consumption per week ) drug Smoking Plans lose weight follow hypocaloric diet ; Use medication , include vitamin supplementation , except oral contraceptive , within 14 day prior test ; Regular use laxation product ; Use antibiotic 90 day prior start study . Administration investigational drug participation scientific intervention study may interfere study ( decided principle investigator ) , 180 day prior study Known pregnancy , lactation ( checked pregnancy test start study ) Blood donation within 3 month study period Prohibited use pro , pre synbiotics study period three month prior start study . A list forbidden product provide ( E4 PreProbiotics ) . Selfadmitted HIVpositive state History side effect towards intake pro prebiotic supplement kind</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Prebiotics</keyword>
	<keyword>Intestinal permeability</keyword>
	<keyword>Gut barrier function</keyword>
	<keyword>Immunity</keyword>
</DOC>